Dr. Reddy's Laboratories Ltd.
₹1,275.6-0.39%Dec 16, 11:00 AM IST
DRREDDY•Health Technology•Pharmaceuticals: Major
Current Price
₹1,275.6-0.39%
Dec 16, 11:00 AM ISTMarket Cap₹1,06,749.81 Cr
Market Cap₹1,06,749.81 Cr
Business Overview
Dr. Reddy's Laboratories Limited operates through 3 main business divisions including Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Strategic Growth Areas / Other Businesses.
Business Hierarchy Structure for Dr. Reddy's Laboratories Limited
- Dr. Reddy's Laboratories Limited
- Global Generics
- Branded Generics
- Unbranded Generics
- Biosimilars
- North America Generics (NAG)
- Authorized Generics
- Finasteride 5mg
- Simvastatin
- Lenalidomide Capsules
- Reditux (Rituximab Biosimilar)
- Cresp (Darbepoetin alfa)
- Authorized Generics
- Europe
- Histallay (Allergy Medication)
- Nerivio® (Migraine Management Device)
- Emerging Markets
- Russia
- China
- Olanzapine
- India
- Reditux (Rituximab Biosimilar)
- Cresp (Darbepoetin alfa)
- Nerivio® (Migraine Management Device)
- DailyBloom™ (IBS Condition Management Platform)
- Sanofi vaccine portfolio
- Hexaxim
- Pentaxim
- Tetraxim
- Menactra
- FluQuadri
- Adacel
- Avaxim 80U
- Pharmaceutical Services and Active Ingredients (PSAI)
- API Business
- Pharmaceutical Services Business
- Aurigene Oncology Limited
- Drug Discovery
- Early Clinical Development of Novel Therapies
- Strategic Growth Areas / Other Businesses
- Consumer Health
- Premama® (Dietary Supplements)
- MenoLabs® (Women's Health and Dietary Supplements)
- Histallay (OTC Allergy Medication)
- Nicotinell (OTC Allergy Medication)
- Nestlé India JV (Nutraceutical Brands)
- Digital Health Solutions
- Nerivio® (Migraine Management Device)
- DailyBloom™ (IBS Condition Management Platform)
- Access to Novel Molecules
- CAR-T (India)
- Toripalimab (Oncology Molecule)
- COYA 302 (Investigational Biologic for ALS)
- Pyrotinib (Oral Breast Cancer NCE)
- Centhaquine (Hypovolemic Shock Drug)
- Consumer Health
- Global Generics